GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glow LifeTech Corp (XCNQ:GLOW) » Definitions » ROCE %

Glow LifeTech (XCNQ:GLOW) ROCE % : -672.81% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Glow LifeTech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Glow LifeTech's annualized ROCE % for the quarter that ended in Sep. 2023 was -672.81%.


Glow LifeTech ROCE % Historical Data

The historical data trend for Glow LifeTech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glow LifeTech ROCE % Chart

Glow LifeTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22
ROCE %
- - -724.30 -98.59

Glow LifeTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -52.63 -215.55 -139.59 -255.69 -672.81

Glow LifeTech ROCE % Calculation

Glow LifeTech's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-2.268/( ( (3.764 - 0.328) + (2.308 - 1.143) )/ 2 )
=-2.268/( (3.436+1.165)/ 2 )
=-2.268/2.3005
=-98.59 %

Glow LifeTech's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=-1.46/( ( (2.128 - 1.707) + (1.996 - 1.983) )/ 2 )
=-1.46/( ( 0.421 + 0.013 )/ 2 )
=-1.46/0.217
=-672.81 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glow LifeTech  (XCNQ:GLOW) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Glow LifeTech ROCE % Related Terms

Thank you for viewing the detailed overview of Glow LifeTech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glow LifeTech (XCNQ:GLOW) Business Description

Traded in Other Exchanges
Address
65 International Boulevard, Suite 206, Etobicoke, ON, CAN, M9W 6L9
Glow LifeTech Corp is a biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption, and effectiveness. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Executives
Daniel Proska Director

Glow LifeTech (XCNQ:GLOW) Headlines

No Headlines